Professor Clive Wilson

Research Professor

Strathclyde Institute of Pharmacy and Biomedical Sciences

Personal statement

Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University and serves on the European Union Federation of Pharmaceutical Sciences teaching and overseas liaison committee. He completed his Ph.D. with Professor Dennis Parke in drug metabolism at the University of Surrey. His first position was an Asthma Research Council Fellow at the Cardiothoracic Institute, London becoming a Lecturer in Biochemical Pharmacology and moving to Nottingham Medical School to become Reader in Applied Pharmacology.

Major areas of research have been the study of the behaviour of drug formulations in man. With colleagues at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects on drug absorption following oral, nasal, pulmonary and ophthalmic delivery. In the university, his group collaborates with industry on ophthalmic drug delivery projects especially related to the behaviour of ocular implants. He is a member of the steering group of the IMI OrBiTo programme and co-manages the Strathclyde group with Professor Gavin Halbert. Recent new areas of interest include additive soft and hard matrix technologies for drug delivery, and several programmes in novel therapies for treating ulcerative colitis.

Primary Teaching activities are in the field of Biopharmaceutics and formulation research.


In vitro dissolution testing models of ocular implants for posterior segment drug delivery
Adrianto Muhammad Faris, Annuryanti Febri, Wilson Clive G, Sheshala Ravi, Thakur Raghu Raj Singh
Drug Delivery and Translational Research (2021)
Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics : an UNGAP review
Vinarov Zahari, Abdallah Mohammad, Agundez José AG, Allegaert Karel, Basit Abdul W, Braeckmans Marlies, Ceulemans Jens, Corsetti Maura, Griffin Brendan T, Grimm Michael, Keszthelyi Daniel, Koziolek Mirko, Madla Christine M, Matthys Christophe, McCoubrey Laura E, Mitra Amitava, Reppas Christos, Stappaerts Jef, Steenackers Nele, Trevaskis Natalie L, Vanuytsel Tim, Vertzoni Maria, Weitschies Werner, Wilson Clive, Augustijns Patrick
European Journal of Pharmaceutical Sciences Vol 162 (2021)
Current challenges and future perspectives in oral absorption research : an opinion of the UNGAP network
Vinarov Zahari, Abrahamsson Bertil, Artursson Per, Batchelor Hannah, Berben Philippe, Bernkop-Schnürch Andreas, Butler James, Ceulemans Jens, Davies Nigel, Dupont Didier, Flaten Gøril Eide, Fotaki Nikoletta, Griffin Brendan T, Jannin Vincent, Keemink Janneke, Kesisoglou Filippos, Koziolek Mirko, Kuentz Martin, Mackie Alan, Meléndez-Martínez Antonio J, McAllister Mark, Müllertz Anette, O'Driscoll Caitriona M, Parrott Neil, Paszkowska Jadwiga, Pavek Petr, Porter Christopher JH, Reppas Christos, Stillhart Cordula, Sugano Kiyohiko, Toader Elena, Valentová Kateřina, Vertzoni Maria, De Wildt Saskia N, Wilson Clive G, Augustijns Patrick
Advanced Drug Delivery Reviews Vol 171, pp. 289-331 (2021)
Multidimensional analysis of human intestinal fluid composition
Pyper Kate, Brouwers Joachim, Augustijns Patrick, Khadra I, Dunn C, Wilson CG, Halbert GW
European Journal of Pharmaceutics and Biopharmaceutics Vol 153, pp. 226-240 (2020)
Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid
McPherson Stephanie, Perrier Jeremy, Dunn Claire, Khadra Ibrahim, Davidson Scott, Ainousah Bayan, Wilson Clive G, Halbert Gavin
European Journal of Pharmaceutics and Biopharmaceutics Vol 150, pp. 14-23 (2020)
An interlaboratory investigation of intrinsic dissolution rate determination using surface dissolution
Etherson Kelly, Dunn Claire, Matthews Wayne, Pamelund Henrik, Barragat Camille, Sanderson Natalie, Izumi Toshiko, da Costa Mathews Claudia, Halbert Gavin, Wilson Clive, McAllister Mark, Mann James, Østergaard Jesper, Butler James, Khadra Ibrahim
European Journal of Pharmaceutics and Biopharmaceutics Vol 150, pp. 24-32 (2020)

More publications

Research interests

Steering Group, European Federation for Pharmaceutical Sciences

Professional activities

European Federation of Pharmaceutical Sciences (External organisation)
EUFEPS Conference on Bioavailability and Bioequivalence , Greece
Keynote/plenary speaker
CRS Book Series Editorial Board
Editorial board member
34th Controlled Release Society Conference, USA
Keynote/plenary speaker
10th Rotterdam Glaucoma Symposium, Netherlands
Keynote/plenary speaker
Philips Medimetrics (External organisation)

More professional activities


Retinal Drug Delivery
Khadra, Ibrahim (Principal Investigator) Wilson, Clive (Principal Investigator) Dunn, Claire (Researcher)
The Allergan project focuses on API infused PLGA implants for ocular drug delivery. These implants are bio-degradable meaning there is no need for surgical removal of the implant. The research currently focuses on investigating the degradation of the implants at 37oC (body temperature) and 50oC (to develop an accelerated degradation model) and observing if agitation has a significant effect on degradation rate. Implants were then fully characterised to determine the physical and chemical degradation effects.
01-Jan-2017 - 31-Jan-2019
EPSRC Doctoral Training Grant - DTA, University of Strathclyde | Brownlee, William John
Seib, Philipp (Principal Investigator) Wilson, Clive (Co-investigator) Brownlee, William John (Research Co-investigator)
01-Jan-2015 - 11-Jan-2019
EPSRC Doctoral Training Grant - DTA, University of Strathclyde | Huff Guelbert, Samuel
Seib, Philipp (Principal Investigator) Wilson, Clive (Co-investigator) Huff Guelbert, Samuel (Research Co-investigator)
01-Jan-2013 - 17-Jan-2017
Medical Devices Doctoral Training Centre Renewal | Hall Barrientos, Ivan
Wilson, Clive (Principal Investigator) Black, Richard Anthony (Co-investigator) Hall Barrientos, Ivan (Research Co-investigator)
01-Jan-2013 - 29-Jan-2018
Optical and Magnetic Non-Invasive Flow and manipulation platform for controlling nanomanufacture of pharmaceuticals, nanoparticles, and other nanostructured materials
Haw, Mark (Principal Investigator) Wilson, Clive (Co-investigator) Zagnoni, Michele (Co-investigator) Wark, Alastair (Co-investigator)
micromanipulation non-invasively in nanomaterial manufacture processes, to enhance direct control of nucleation, growth and structure development. Nucleation and assembly are the first stage of engineering nanostructured materials in applications including drug crystallisation, nanoparticle and nanoporous catalyst manufacture, and metal-organic frameworks for molecular storage. There is significant evidence that these complex microscale nucleation and assembly processes are strongly affected by local conditions such as flow. Our understanding of how flow and local (at the micron-scale) forces affect and thus could be used to control nanostructure nucleation is limited, because nucleation is inherently a local process while flow and external forces are usually applied globally. Therefore our novel, versatile OMNIFlow experimental platform will non-invasively impose local micron-scale flows by manipulating optically and magnetically trapped particles, generating local flow fields in the nucleating or assembling suspension. The project brings together Strathclyde expertise in microfluidics, optical and magnetic manipulation and quantitative dynamic microscopy, and focusses on applications in the key Strathclyde research strength of advanced nanomaterial engineering and science for innovative industrial applications. It will provide a unique experimental platform to highlight Strathclyde’s developing central role in this area.
01-Jan-2013 - 02-Jan-2013
Oral Biopharmaceutics "Orbito"
Khadra, Ibrahim (Principal Investigator) Wilson, Clive (Principal Investigator) Halbert, Gavin (Principal Investigator)
Through partnership, collaboration and data sharing, we will develop our fundamental knowledge of the gastrointestinal environment to deliver innovative biopharmaceutics tools which will accurately predict product performance over a range of clinically relevant conditions. The integration of in vitro and in silico approaches will provide a biopharmaceutics toolkit, validated using clinical data, to accelerate drug development
01-Jan-2012 - 01-Jan-2019

More projects


Strathclyde Institute of Pharmacy and Biomedical Sciences
Robertson Wing

Location Map

View University of Strathclyde in a larger map